Additional file 1. CDG state of the art until 2022: glycosylation pathways, phenotypes, genotypes, inheritance patterns, biomarkers, disease models, and treatments.
Additional file 1. CDG state of the art until 2022: glycosylation pathways, phenotypes, genotypes, inheritance patterns, biomarkers, disease models, and treatments.
The Congenital Disorders of Glycosylation (CDG) are a devastating group of genetic disorders that encompass a spectrum of glycosylation defects and are characterized by the underglycosylation of or th
